StockNews.com started coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research note issued to investors on Friday. The firm issued a hold rating on the biotechnology company’s stock.
Bellerophon Therapeutics Stock Performance
Shares of NASDAQ:BLPH opened at $0.04 on Friday. Bellerophon Therapeutics has a 1-year low of $0.03 and a 1-year high of $0.46. The business has a 50-day moving average price of $0.04 and a two-hundred day moving average price of $0.05. The stock has a market capitalization of $428,050.00, a P/E ratio of -0.04 and a beta of 0.70.
Bellerophon Therapeutics Company Profile
See Also
- Five stocks we like better than Bellerophon Therapeutics
- When to Sell a Stock for Profit or Loss
- Powering Your Portfolio: The Utility Sector’s Electrifying Surge
- Best Aerospace Stocks Investing
- Adobe Stock Builds Long-Term Value: Consider Buying on the Dip
- The How And Why of Investing in Oil Stocks
- Albemarle Jumps as Lithium Stock Buying Frenzy Takes Off
Receive News & Ratings for Bellerophon Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellerophon Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
